Lexaria Bioscience Corp (LEXX)

$0.95 +0.01 (0.69%)
Market Cap 23.39M
Revenue (ttm) 710,000.00
Net Income (ttm) -11.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,676.06%
Debt to Equity Ratio 0.00
Volume 104,870
Avg Vol 169,200
Day's Range N/A - N/A
Shares Out 24.79M
Stochastic %K 27%
Beta 0.48
Analysts Strong Sell
Price Target $4.50

Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is...

Industry: Biotechnology
Sector: Healthcare
Phone: 250 765 6424
Address:
740 McCurdy Road, Suite 100, Kelowna, Canada
Makingmillions192
Makingmillions192 Apr. 27 at 8:05 PM
$LEXX Bueller… Bueller?
0 · Reply
hovian
hovian Apr. 27 at 7:32 PM
$LEXX we need to build confidence ... if the ask is not taken down we go....
0 · Reply
hovian
hovian Apr. 27 at 7:29 PM
$LEXX if someone get that under 97 ask this will fly till 1.05 imho
0 · Reply
hovian
hovian Apr. 27 at 6:33 PM
$LEXX lexx see if anyone have the impression this is going up on april 30th... if is the case 20k ask should be taken sonner than later
0 · Reply
hovian
hovian Apr. 27 at 6:03 PM
$LEXX okay lexx see if .965 ask 14k is taken
0 · Reply
hovian
hovian Apr. 27 at 5:57 PM
$LEXX at one price I will assume I m always wrong ? my bad... I so tired to be almost always wrong...
1 · Reply
Makingmillions192
Makingmillions192 Apr. 27 at 5:57 PM
$LEXX I swear I’ve done more work putting out the word about Lexaria than the mgmt team 😂 The silence is deafening…
0 · Reply
hovian
hovian Apr. 27 at 5:52 PM
$LEXX Someone put a lot of water in my wine... is bot letting pick up... how scare will be if this scales to 1.1 ?
0 · Reply
Makingmillions192
Makingmillions192 Apr. 27 at 5:30 PM
$LEXX 1H is super bullish and the 4H is going to cross over. Next leg firing up 🔥
0 · Reply
Makingmillions192
Makingmillions192 Apr. 27 at 5:19 PM
$LEXX Technicals looking great - if buying volume kicks up this will be in a hurry quick
0 · Reply
Latest News on LEXX
Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs

Apr 23, 2026, 9:05 AM EDT - 4 days ago

Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs

Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales

Apr 21, 2026, 9:10 AM EDT - 6 days ago

Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

Apr 15, 2026, 9:10 AM EDT - 12 days ago

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval

Apr 7, 2026, 9:10 AM EDT - 20 days ago

Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval

Lexaria to Begin New Human Clinical Study in GLP-1

Apr 1, 2026, 9:20 AM EDT - 26 days ago

Lexaria to Begin New Human Clinical Study in GLP-1

Lexaria's Robust Patent Portfolio Continues to Grow

Mar 26, 2026, 9:20 AM EDT - 4 weeks ago

Lexaria's Robust Patent Portfolio Continues to Grow

Lexaria's Oral GLP-1 Drug Strategy Validated by Industry

Mar 24, 2026, 9:15 AM EDT - 4 weeks ago

Lexaria's Oral GLP-1 Drug Strategy Validated by Industry

Lexaria Announces New R&D Plans for 2026

Mar 4, 2026, 9:25 AM EST - 7 weeks ago

Lexaria Announces New R&D Plans for 2026

Lexaria Announces Positive Final Results From Human Pilot Study #5

Feb 5, 2026, 9:15 AM EST - 2 months ago

Lexaria Announces Positive Final Results From Human Pilot Study #5

Lexaria Awarded Six Additional Patents

Jan 22, 2026, 9:20 AM EST - 3 months ago

Lexaria Awarded Six Additional Patents

Lexaria Releases Annual Letter from the CEO

Jan 12, 2026, 9:10 AM EST - 3 months ago

Lexaria Releases Annual Letter from the CEO

Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4

Dec 30, 2025, 9:20 AM EST - 4 months ago

Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4

Lexaria Says Oral GLP-1 Cuts Side Effects Nearly 50% Versus Novo Nordisk's Rybelsus

Dec 23, 2025, 12:06 PM EST - 4 months ago

Lexaria Says Oral GLP-1 Cuts Side Effects Nearly 50% Versus Novo Nordisk's Rybelsus

NVO

Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4

Dec 23, 2025, 9:29 AM EST - 4 months ago

Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4

Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Dec 16, 2025, 4:00 PM EST - 4 months ago

Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Dec 15, 2025, 8:00 AM EST - 4 months ago

Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended

Nov 12, 2025, 9:10 AM EST - 5 months ago

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended

Lexaria Bioscience Corp. Provides Strategic Update

Oct 9, 2025, 9:20 AM EDT - 7 months ago

Lexaria Bioscience Corp. Provides Strategic Update

Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 29, 2025, 4:30 PM EDT - 7 months ago

Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 26, 2025, 8:10 AM EDT - 7 months ago

Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain

Sep 19, 2025, 11:20 AM EDT - 7 months ago

Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain

Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone

Aug 14, 2025, 9:20 AM EDT - 9 months ago

Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone

GLP-1 "Arms Race" Broadens to Include Dozens of Companies

Aug 6, 2025, 9:20 AM EDT - 9 months ago

GLP-1 "Arms Race" Broadens to Include Dozens of Companies

Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study

Jul 28, 2025, 9:25 AM EDT - 9 months ago

Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study

Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry

Jul 23, 2025, 9:25 AM EDT - 9 months ago

Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry

Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company

May 12, 2025, 9:00 AM EDT - 1 year ago

Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company

Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock

Apr 28, 2025, 4:15 PM EDT - 1 year ago

Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock

Lexaria Announces $2 Million Registered Direct Offering of Common Stock

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Lexaria Announces $2 Million Registered Direct Offering of Common Stock

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience's Technology

Apr 23, 2025, 9:10 AM EDT - 1 year ago

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience's Technology

Lexaria Updates its Ongoing Human Study GLP-1-H24-4

Apr 3, 2025, 9:10 AM EDT - 1 year ago

Lexaria Updates its Ongoing Human Study GLP-1-H24-4

Lexaria's Human GLP-1 Study #5 Begins Dosing

Apr 2, 2025, 9:05 AM EDT - 1 year ago

Lexaria's Human GLP-1 Study #5 Begins Dosing

Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound(R)

Mar 18, 2025, 9:15 AM EDT - 1 year ago

Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly's Injectable Zepbound(R)

The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience

Feb 27, 2025, 8:00 AM EST - 1 year ago

The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience

Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm

Feb 24, 2025, 8:00 AM EST - 1 year ago

Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm

Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide

Feb 20, 2025, 8:00 AM EST - 1 year ago

Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide

Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy

Feb 11, 2025, 8:00 AM EST - 1 year ago

Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy

Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway

Feb 6, 2025, 9:40 AM EST - 1 year ago

Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway

Lexaria's Human GLP-1 Study #5 Receives Independent Review Board Approval

Jan 15, 2025, 9:20 AM EST - 1 year ago

Lexaria's Human GLP-1 Study #5 Receives Independent Review Board Approval

Lexaria's Oral DehydraTECH-Tirzepatide Reduces Side Effects by Half with Comparable Efficacy Versus Eli Lilly's Injectable GLP-1/GIP Drug Zepbound(R)

Jan 14, 2025, 9:10 AM EST - 1 year ago

Lexaria's Oral DehydraTECH-Tirzepatide Reduces Side Effects by Half with Comparable Efficacy Versus Eli Lilly's Injectable GLP-1/GIP Drug Zepbound(R)

Lexaria's Registered GLP-1 Study #4 Begins Dosing

Dec 19, 2024, 9:05 AM EST - 1 year ago

Lexaria's Registered GLP-1 Study #4 Begins Dosing

Lexaria Forms New Scientific Advisory Board

Dec 18, 2024, 9:25 AM EST - 1 year ago

Lexaria Forms New Scientific Advisory Board

Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience

Dec 17, 2024, 9:10 AM EST - 1 year ago

Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience

Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5

Dec 9, 2024, 9:10 AM EST - 1 year ago

Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5

Revolutionizing Healthcare: Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs

Nov 26, 2024, 9:20 AM EST - 1 year ago

Revolutionizing Healthcare: Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs

Makingmillions192
Makingmillions192 Apr. 27 at 8:05 PM
$LEXX Bueller… Bueller?
0 · Reply
hovian
hovian Apr. 27 at 7:32 PM
$LEXX we need to build confidence ... if the ask is not taken down we go....
0 · Reply
hovian
hovian Apr. 27 at 7:29 PM
$LEXX if someone get that under 97 ask this will fly till 1.05 imho
0 · Reply
hovian
hovian Apr. 27 at 6:33 PM
$LEXX lexx see if anyone have the impression this is going up on april 30th... if is the case 20k ask should be taken sonner than later
0 · Reply
hovian
hovian Apr. 27 at 6:03 PM
$LEXX okay lexx see if .965 ask 14k is taken
0 · Reply
hovian
hovian Apr. 27 at 5:57 PM
$LEXX at one price I will assume I m always wrong ? my bad... I so tired to be almost always wrong...
1 · Reply
Makingmillions192
Makingmillions192 Apr. 27 at 5:57 PM
$LEXX I swear I’ve done more work putting out the word about Lexaria than the mgmt team 😂 The silence is deafening…
0 · Reply
hovian
hovian Apr. 27 at 5:52 PM
$LEXX Someone put a lot of water in my wine... is bot letting pick up... how scare will be if this scales to 1.1 ?
0 · Reply
Makingmillions192
Makingmillions192 Apr. 27 at 5:30 PM
$LEXX 1H is super bullish and the 4H is going to cross over. Next leg firing up 🔥
0 · Reply
Makingmillions192
Makingmillions192 Apr. 27 at 5:19 PM
$LEXX Technicals looking great - if buying volume kicks up this will be in a hurry quick
0 · Reply
hovian
hovian Apr. 27 at 5:15 PM
$LEXX I belive is gonna pick up... just my guts... lexx see...
0 · Reply
hovian
hovian Apr. 27 at 4:07 PM
$LEXX wanna see +1$ !!!!
0 · Reply
paolo73
paolo73 Apr. 27 at 3:19 PM
$LEXX 3 day for mta
1 · Reply
Makingmillions192
Makingmillions192 Apr. 27 at 2:25 PM
$LEXX It looks like someone finally bought that ~30k wall that kept popping up.. 📊
0 · Reply
Makingmillions192
Makingmillions192 Apr. 27 at 2:20 PM
$LEXX Nice buy right there, she’s looking primed 📈
0 · Reply
The_Wealth_Maker
The_Wealth_Maker Apr. 27 at 2:14 PM
$LEXX
0 · Reply
hovian
hovian Apr. 27 at 2:00 PM
$LEXX we going to need a 200-300k shares buying the ask to go more than 1$ kmon just buy till shorters panic... Is this a sign that someone is not letting SP go up to preserve a all shares buy price as low as can?
1 · Reply
Makingmillions192
Makingmillions192 Apr. 27 at 1:47 PM
$LEXX Gap closed from Friday - let’s goo 🏎️ 💨 Smack that ask 👋
0 · Reply
Makingmillions192
Makingmillions192 Apr. 27 at 1:33 PM
$LEXX First of many buys today
0 · Reply
Makingmillions192
Makingmillions192 Apr. 27 at 1:31 PM
$LEXX Looks like we are getting a breakout
0 · Reply
Makingmillions192
Makingmillions192 Apr. 27 at 1:30 PM
$LEXX Nice open 👀 $1 🚀
0 · Reply
Makingmillions192
Makingmillions192 Apr. 27 at 1:17 PM
$LEXX This hope this week is D-Day!!! With the April 30th MTA deadline hitting Thursday, we are officially in the "D-Day" window for Lexaria. After months of Big Pharma auditing a 7,000-page dataset and clinical teams de-risking the tech, the silence is deafening. Between the 55% side-effect reduction and the "fed-state" delivery breakthrough, the leverage is all on our side. This isn't just another Thursday—it’s the moment the "Pill War" gets its winner. Big Pharma needs the technology, mid size pharma wants the tech. Let’s see who wins 🔔 📈 The spring is coiled 🚀💊 $NVO $LLY $PFE
0 · Reply